These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31000432)

  • 1. Ample evidence for statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention.
    Shariff M; Kumar U A
    Cardiovasc Revasc Med; 2019 Jun; 20(6):533-534. PubMed ID: 31000432
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Soud M; Ho G; Kuku KO; Hideo-Kajita A; Waksman R; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2018 Dec; 19(8):971-975. PubMed ID: 30056022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.
    Pan Y; Tan Y; Li B; Li X
    Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI.
    Lampropoulos K; Megalou A; Bazoukis G; Tse G; Manolis A
    J Interv Cardiol; 2017 Dec; 30(6):507-513. PubMed ID: 28786142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.
    Zhang F; Dong L; Ge J
    Ann Med; 2010 Apr; 42(3):171-7. PubMed ID: 20384433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
    Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies.
    Xiao Y; He S; Zhang Z; Feng H; Cui S; Wu J
    Med Sci Monit; 2018 Dec; 24():9166-9176. PubMed ID: 30557296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients.
    Soud M; Hideo-Kajita A; Ho G; Yacob O; Alahdab F; King F; Waksman R; McFadden EP; Garcia-Garcia HM
    Coron Artery Dis; 2020 Mar; 31(2):137-146. PubMed ID: 31609755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statins therapy prior to percutaneous coronary intervention.
    Luo J; Xu L; Yu T; Li J
    J Interv Cardiol; 2012 Apr; 25(2):156-62. PubMed ID: 22248354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
    Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
    Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of randomized trials.
    Mega S; Patti G; Cannon CP; Di Sciascio G
    Crit Pathw Cardiol; 2010 Mar; 9(1):19-22. PubMed ID: 20215906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
    Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
    PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
    Li JS; Zhao XJ; Ma BX; Wang Z
    J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
    Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis.
    Zhai C; Cong H; Liu Y; Zhang Y; Liu X; Zhang H; Ren Z
    Clin Cardiol; 2015 Nov; 38(11):668-78. PubMed ID: 26442621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.